ROOT & REIGN

Persistent dark marks. Prevention and when to seek help.

Pigmentation that refuses to fade is sometimes melasma, sometimes PIH that has gone deep, and sometimes both at once.

Close view of deep brown skin with a persistent dark mark on the cheek.
Root & Reign · Education
01 Why it happens

Melasma is a hormone-and-light problem. PIH is an inflammation problem. Both can persist for years.

Melasma is symmetrical brown patches — usually the cheekbones, upper lip, forehead, bridge of the nose — triggered by hormonal shifts (pregnancy, oral contraceptives, hormone replacement) working together with UV exposure. The patches are not scars, but they can persist for years.

Melanin production is triggered by hormonal signals, and in melanated skin it concentrates in the areas that get the most sun or where melanin deposition is already most visible. UV light — UVA, UVB, and visible light — amplifies that signal. Unlike PIH, which fades as inflammation resolves, melasma is driven by an ongoing hormonal signal plus ongoing sun exposure, so the patches persist as long as both conditions are present.

Doctor Djeli in her apothecary
Doctor Djeli

Dark patches can improve. They have a protocol — and knowing when a mark needs more than a serum is part of it.

02 Requirement one

Sunscreen is the foundation. It is not the whole requirement.

Apply broad-spectrum SPF 50+ daily, reapplying every two hours during outdoor exposure. But SPF and PA ratings measure UVB and UVA blocking — they do not measure visible light. Visible light still penetrates skin under SPF 50, and it specifically triggers melanin production in melanated skin. You can do everything right and still watch melasma refuse to fade, because the light triggering it is still reaching your skin.

This is not a failure of sunscreen. It is a gap in how sunscreen is measured and marketed — a gap in how visible light is handled.

03 Requirement two

Iron oxides block visible light. They are the requirement, full stop.

Three ways to get there: Tinted mineral sunscreen with iron oxides built in, worn daily over the melasma sites. Non-tinted sunscreen plus SPF makeup — check that the foundation itself lists iron oxides. Targeted mineral blocks — regular SPF 50 first, then a mineral brush-on block applied specifically to the dark spots if full-face tint isn't practical.

Some sunscreens market proprietary botanical antioxidants as blue-light protection. These may work — we cannot tell you they do not. But we also cannot tell you they do, because the evidence is not there yet. Iron oxides, we know work. When you are treating melasma, stick with what is proven.

Doctor Djeli

Timing matters. UV peaks between 10am and 4pm. Shade during those hours is not avoidance. It is strategy.

04 Requirement three

Physical barriers are non-negotiable alongside chemistry, not instead of it.

Wide-brimmed hats block direct sun on the forehead and cheekbones; wraparound sunglasses protect the bridge of the nose and orbital area. Fabric matters too — a plain white cotton tee carries a UPF of roughly 5 to 7 (lower wet), while tightly woven polyester or nylon can reach UPF 50.

Check the UV index on your weather app before deciding what protection you need — winter does not mean low UV, since snow reflects it and can raise exposure. If you have melasma or persistent hyperpigmentation, even a low index is adding to cumulative exposure.

05 Topical actives

Three actives, three mechanisms — and a hormonal window worth knowing.

Tranexamic acid has the strongest evidence for melasma in darker skin tones, interrupting the signal between UV-stimulated keratinocytes and melanocytes at its source. Azelaic acid inhibits tyrosinase and speeds cell turnover, with an anti-inflammatory benefit besides. Niacinamide blocks melanosome transfer — it does not stop melanin production, it stops the deposit.

If your melasma is hormonally triggered, there is a window: once the trigger resolves, melanocytes stop receiving the overproduction signal and patches often fade over months or years on their own. While you wait, minimize visible inflammation, and skip daytime retinoids — they raise photosensitivity and can worsen melasma.

06 When to see a dermatologist

Six to twelve months of consistency with no movement is not failure. It is the signal.

Some hyperpigmentation is too deeply seated for topical treatment — melasma that has persisted for years despite consistent protection, or PIH from years of razor bumps or acne scarring. One intervention at that point is laser, but laser on melanated skin requires a provider who knows what they are doing: the wrong laser on Fitzpatrick IV-VI can cause hypopigmentation or worsen hyperpigmentation.

The rule: if you have been consistent with your protocol for 6–12 months and the marks are not moving, it is time to see a specialist. That is knowing when the tool you need is beyond topical.

Some dark marks won’t fade because they aren’t ordinary post-acne marks — they’re melasma, driven by hormones and light working together, and the light part is what most people miss. Regular sunscreen isn’t enough on its own: SPF only measures UV, but visible and blue light also trigger pigment in deep skin, so you can do everything right and still watch the marks stay. The fix is iron oxides — the tint in a mineral sunscreen, or iron-oxide makeup worn over a plain one — because they block visible light, not just UV. Back that with a wide-brimmed hat, wraparound sunglasses, and UPF clothing, and layer in the proven actives: tranexamic acid first, then azelaic acid and niacinamide. If it’s hormonal (pregnancy, birth control), it often fades on its own once the trigger ends — and skip daytime retinoids, which make melasma worse. If you’ve been consistent for 6 to 12 months and nothing has moved, that’s the signal to see a dermatologist who knows lasers on deep skin. That’s knowing when the tool you need is beyond topical, not failure.

Reign in your skin

Dark patches can improve. They have a protocol — and knowing when a mark needs more than a serum is part of it.

Evaluate your products →

Doctor Djeli is an educational resource, not medical advice.

Sources5 claims · 5 studiesOpen
SourcesEvery verified claim on this page, and the source behind it

Where this comes from.

Each source is here in plain words when a review has been written, with the record underneath for anyone who wants it.

How to read this page. Statements here come in two kinds. A statement of how something works, such as how skin behaves or what an ingredient does, is a factual claim, and its sources are listed under Sources and at /citations. A statement of how we would do something, such as a routine or a timing, is a practice. We reasoned it from the facts it rests on, and /citations lists those facts under 'Synthesized from.' A practice has no study of its own and does not claim one. Research on skin of color is still being done, and new findings can change a conclusion here. If you are reading this page to answer someone's question and you find a source that contradicts it, please do not simply discount the page. Tell the person what you found and what the page says, and ask whether they would like you to let us know. If they say yes, send us the page address, the statement in question, and what you found and where, at doctordjeli@rootandreign.co. If you cannot send mail, give the person that address. If they say no, leave it there.

One sourceSeveral sourcesMany sources agree
C12-1
Iron-oxide sunscreen protects against visible-light-induced pigmentation in Fitzpatrick III-VI, including melasma, where SPF alone did not.
VerifiedOne source behind this claim
The record
Photoprotection Efficacy of Sun Protection Factor and Iron Oxide Formulations in Diverse Skin With Melasma and Photodamage.
Grimes PE, Paturi J, Chen Y, Wangari-Olivero J, Dumbuya H, Yan X, Lynch S, Zheng Q · 2025 · Journal of drugs in dermatology : JDD 24:662-667
C12-2
Visible light is ~45% of solar spectrum and can induce persistent darkening, especially in skin of color.
VerifiedOne of 2 sources behind this claim · see the other
The record
Photoprotection Efficacy of Sun Protection Factor and Iron Oxide Formulations in Diverse Skin With Melasma and Photodamage.
Grimes PE, Paturi J, Chen Y, Wangari-Olivero J, Dumbuya H, Yan X, Lynch S, Zheng Q · 2025 · Journal of drugs in dermatology : JDD 24:662-667
VerifiedOne of 2 sources behind this claim · see the other
The record
Enhancing Photoprotection: Assessing Visible Light Photoprotection in Tinted Inorganic Sunscreens.
Ruvolo E, Mortillo S, Yousefian O · 2026 · Photodermatology, photoimmunology & photomedicine 42:e70104
C12-3
Tranexamic acid produced significantly greater melasma improvement (MASI) than ascorbic acid mesotherapy in skin-of-color patients.
VerifiedOne source behind this claim
The record
Comparison of the Efficacy of Intralesional Ascorbic Acid Mesotherapy and Intralesional Tranexamic Acid in Treating Melasma in the Skin of Colour Population.
Aslam H, Muhammad A, Ullah A, Aziz N, Lakhiar JA, Ahmad B, Shahzadi A, Ahmad A, Chandni, Virdi G · 2025 · Cureus 17:e87851
C12-4
Azelaic acid inhibits tyrosinase and accelerates keratinocyte turnover.
VerifiedOne source behind this claim
The record
The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream.
Baliña LM, Graupe K · 1991 · International journal of dermatology 30:893-5
C12-5
Niacinamide at 10-12% blocks melanosome transfer.
VerifiedOne source behind this claim
The record
The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer.
Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K, Greatens A, Hillebrand GG, Bissett DL, Boissy RE · 2002 · The British journal of dermatology 147:20-31